Announcements Trials

Browse Landscape

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms 1 Mesothelioma 1 Melanoma 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Adenoma, Islet Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Histocompatibility Testing × Clear all

NCT04804878 2021-03-18

MSMTCC

Morehouse School of Medicine

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡